5 results match your criteria: "National Cancer Centre Hospital Tokyo Japan.[Affiliation]"
Article Synopsis
- The study aimed to assess the effectiveness of an antiadhesion membrane in preventing postoperative small bowel obstruction (SBO) in patients undergoing open gastrectomy for gastric cancer, following prior evidence of its use in other surgeries. !* -
- Out of 1204 participants in the JCOG1001 trial, 1200 were analyzed, identifying that factors like total gastrectomy and significant blood loss heightened the risk of SBO, but the antiadhesion membrane offered no protective benefit against it. !* -
- The findings concluded that the antiadhesion membrane does not lower the incidence of SBO following open gastrectomy in gastric cancer patients, indicating it should not be used for SBO prevention in this surgical context
Cerebrospinal fluid infiltration of primary cutaneous gamma delta T-cell lymphoma.
EJHaem
February 2022
Department of Laboratory Medicine, National Cancer Centre Hospital Tokyo Japan.
Mixed-phenotype acute leukemia consisting of five heterogeneous leukemic populations without the expression of CD34.
EJHaem
November 2020
Department of Laboratory Medicine, National Cancer Centre Hospital Tokyo Japan.
Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
BJS Open
June 2019
Hepatobiliary and Pancreatic Surgery Division, National Cancer Centre Hospital Tokyo Japan.
Background: Whether the portal/superior mesenteric vein (PV) should be resected during pancreatoduodenectomy for pancreatic ductal adenocarcinoma (PDAC) based on preoperative CT or intraoperative findings is controversial.
Methods: This was a retrospective study with data of patients who had undergone pancreatoduodenectomy for PDAC between 2002 and 2016 in a tertiary referral centre. Based on the extent of contact between the PV and tumour on CT, patients were categorized into: group 1, no contact; group 2, contact 180° or less; group 3, contact greater than 180°.